Bridgewater Associates (Ray Dalio) — VRTX Trade History
Quarter-by-quarter changes in the VERTEX PHARMACEUTICALS INC position · CUSIP 92532F100
Currently held · 1.3 YearsFirst seen: 2017 Q2
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 10,865 | -2,492 | -18.7% | $5.4M | 0.02% |
| 2026 Q1 | 2026-05-15 | Reduce | 13,357 | -14,131 | -51.4% | $6.0M | 0.03% |
| 2025 Q4 | 2026-02-13 | Reduce | 27,488 | -10,836 | -28.3% | $12.5M | 0.04% |
| 2025 Q3 | 2025-11-13 | Add | 38,324 | 3,934 | +11.4% | $15.0M | 0.06% |
| 2025 Q2 | 2025-08-13 | New | 34,390 | 34,390 | — | $15.3M | 0.06% |
| 2025 Q1 | 2025-05-14 | Sold out | — | -710 | -100.0% | — | — |
| 2024 Q4 | 2025-02-13 | Reduce | 710 | -2,742 | -79.4% | $285.9K | 0.00% |
| 2024 Q3 | 2024-11-13 | Reduce | 3,452 | -29,777 | -89.6% | $1.6M | 0.01% |
| 2024 Q2 | 2024-08-14 | Reduce | 33,229 | -101,466 | -75.3% | $15.6M | 0.08% |
| 2024 Q1 | 2024-05-14 | Add | 134,695 | 2,341 | +1.8% | $56.3M | 0.28% |
| 2023 Q4 | 2024-02-14 | Reduce | 132,354 | -25,995 | -16.4% | $53.9M | 0.30% |
| 2023 Q3 | 2023-11-13 | Reduce | 158,349 | -17,964 | -10.2% | $55.1M | 0.33% |
| 2023 Q2 | 2023-08-11 | Reduce | 176,313 | -27,963 | -13.7% | $62.0M | 0.38% |
| 2023 Q1 | 2023-05-12 | Add | 204,276 | 103,457 | +102.6% | $64.4M | 0.39% |
| 2022 Q4 | 2023-02-13 | Reduce | 100,819 | -63,172 | -38.5% | $29.1M | 0.16% |
| 2022 Q3 | 2022-11-10 | Reduce | 163,991 | -53,161 | -24.5% | $47.5M | 0.24% |
| 2022 Q2 | 2022-08-11 | Add | 217,152 | 187,000 | +620.2% | $61.2M | 0.26% |
| 2022 Q1 | 2022-05-13 | Add | 30,152 | 17,735 | +142.8% | $7.9M | 0.03% |
| 2021 Q4 | 2022-02-14 | Reduce | 12,417 | -2,700 | -17.9% | $2.7M | 0.02% |
| 2021 Q3 | 2021-11-12 | Reduce | 15,117 | -8,139 | -35.0% | $2.7M | 0.01% |
| 2021 Q2 | 2021-08-13 | Add | 23,256 | 1,567 | +7.2% | $4.7M | 0.03% |
| 2021 Q1 | 2021-05-14 | Add | 21,689 | 18,059 | +497.5% | $4.7M | 0.04% |
| 2020 Q4 | 2021-02-12 | New | 3,630 | 3,630 | — | $858.0K | 0.01% |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | Sold out | — | -32,260 | -100.0% | — | — |
| 2019 Q3 | 2019-11-13 | New | 32,260 | 32,260 | — | $5.5M | 0.05% |
| 2019 Q2 | 2019-08-13 | Sold out | — | -21,889 | -100.0% | — | — |
| 2019 Q1 | 2019-05-14 | New | 21,889 | 21,889 | — | $4.0M | 0.03% |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q1 | 2018-08-13 | Sold out | — | -15,509 | -100.0% | — | — |
| 2018 Q2 | 2018-08-13 | New | 15,509 | 15,509 | — | $2.6M | 0.03% |
| 2017 Q4 | 2018-02-13 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | Sold out | — | -18,673 | -100.0% | — | — |
| 2017 Q2 | 2017-08-10 | New | 18,673 | 18,673 | — | $2.4M | 0.02% |
| 2017 Q1 | 2017-05-11 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-10 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.